Cargando…

The Extra Cost Due to Non-Adherence to Inhaled Treatments in Adolescents with Mild-to-Moderate Persistent Asthma

Bronchial asthma has a high socio-economic impact in Western countries. Low adherence to prescribed inhalation treatments contributes to poor asthma control and the higher utilization of healthcare resources. Although adolescents usually do not comply with long-term inhaled treatments prescribed on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dal Negro, Roberto Walter, Turco, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137131/ https://www.ncbi.nlm.nih.gov/pubmed/37189865 http://dx.doi.org/10.3390/children10040615

Ejemplares similares

Cost of persistent asthma in Italy
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Effects of Adherence to Once-Daily Treatment on Lung Function, Bronchial Hyperreactivity and Health Outcomes in Adolescents with Mild-to-Moderate Asthmoka: A Twelve-Month Survey
por: Dal Negro, Roberto W., et al.
Publicado: (2022)

Fluticasone furoate/vilanterol 92/22 µg once a day: a 12-month study on outcomes in mild to moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Lung Function Can Predict the Expected Inspiratory Airflow Rate through Dry Powder Inhalers in Asthmatic Adolescents
por: Dal Negro, Roberto Walter, et al.
Publicado: (2022)

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/ Formoterol 100/6 μg b.i.d.: a 12-week cost analysis in mild-to-moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
por: Dal Negro, Roberto W., et al.
Publicado: (2018)

A Bayesian Framework to Assess the Usability of Dry Powder Inhalers in a Cohort of Asthma Adolescents in Italy
por: Dal Negro, Roberto Walter, et al.
Publicado: (2021)

Patients’ usability of seven most used dry-powder inhalers in COPD
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

Correction to: Patients’ usability of seven most used dry-powder inhalers in COPD
por: Dal Negro, Roberto W., et al.
Publicado: (2019)

The Global Usability Score Short-Form for the simplified assessment of dry powder inhalers (DPIs) usability
por: Povero, Massimiliano, et al.
Publicado: (2020)

Cost of acute cough in Italian children
por: Negro, Roberto W Dal, et al.
Publicado: (2018)

Serum interleukin-5 levels are elevated in mild and moderate persistent asthma irrespective of regular inhaled glucocorticoid therapy
por: Joseph, Jose, et al.
Publicado: (2004)

Dry-powder inhalers in patients with persistent airflow limitation: usability and preference
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Instant velocity and consistency of emitted cloud change by the different levels of canister filling with Metered Dose Inhalers (MDIs), but not with Soft Mist Inhalers (SMIs): a bench study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

Medical Costs and Productivity Loss Due to Mild, Moderate, and Severe Asthma in the United States
por: Song, Hyun Jin, et al.
Publicado: (2020)

Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
por: Scaparrotta, Alessandra, et al.
Publicado: (2012)

Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021)

Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients
por: Dal Negro, Roberto W., et al.
Publicado: (2016)

Long-lasting dyspnoea in patients otherwise clinically and radiologically recovered from COVID pneumonia: a probe for checking persisting disorders in capillary lung volume as a cause
por: Dal Negro, Roberto W., et al.
Publicado: (2022)

Coughing Can Be Modulated by the Hydration Status in Adolescents with Asthma
por: Zanasi, Alessandro, et al.
Publicado: (2022)

A Dose-Ranging Study of Epinephrine Hydrofluroalkane Metered-Dose Inhaler (Primatene(®) MIST) in Subjects with Intermittent or Mild-to-Moderate Persistent Asthma
por: Kerwin, Edward M., et al.
Publicado: (2020)

Comparative efficacy of inhalers in mild-to-moderate asthma: systematic review and network meta-analysis
por: Park, Hyung Jun, et al.
Publicado: (2022)

Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence
por: Murphy, Kevin R, et al.
Publicado: (2009)

Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study)
por: Turpeinen, M, et al.
Publicado: (2008)

Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021)

The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patients
por: Dal Negro, Roberto W, et al.
Publicado: (2016)

The Emotional Response to Pandemic of Middle- and High-School Students of an Italian Northern Province: The ERP Study
por: Povero, Massimiliano, et al.
Publicado: (2022)

Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update
por: Dal Negro, Roberto W, et al.
Publicado: (2015)

Efficacy of Low-Dose Ciclesonide and Fluticasone Propionate for Mild to Moderate Persistent Asthma
por: Jamaati, Hamidreza, et al.
Publicado: (2015)

Editorial for “Asthma and Its Impact in Adolescents” Special Issue
por: Dal Negro, Roberto W.
Publicado: (2023)

Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and brochodilators for severe and very severe COPD patients
por: Negro, Roberto Dal, et al.
Publicado: (2007)

Exercise Limitation in Children and Adolescents with Mild-to-Moderate Asthma
por: Lagiou, Olga, et al.
Publicado: (2022)

The impact of adherence and disease control on resource use and charges in patients with mild asthma managed on inhaled corticosteroid agents
por: Navaratnam, P, et al.
Publicado: (2010)

Dry powder inhalers and the right things to remember: a concept review
por: Dal Negro, Roberto W
Publicado: (2015)

Swimming and Persons with Mild Persistant Asthma
por: Aranđelović, Mirjana, et al.
Publicado: (2007)

Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma
por: Vähätalo, Iida, et al.
Publicado: (2021)

Sensitivity of the COPD assessment test (CAT questionnaire) investigated in a population of 681 consecutive patients referring to a lung clinic: the first Italian specific study
por: Negro, Roberto W Dal, et al.
Publicado: (2014)

The contribution of patients’ lung function to the inspiratory airflow rate achievable through a DPIs’ simulator reproducing different intrinsic resistance rates
por: Dal Negro, Roberto W., et al.
Publicado: (2021)

Comparison of Consistency, Feasibility, and Convenience of a Novel Compact System for Assessing Lung Volumes and Carbon Monoxide Diffusing Capacity versus Whole Body Plethysmography
por: Dal Negro, Roberto W, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ktm7atsle13spatvueak9i5n6j